1025967-78-5 Liftegrast
CAS:1025967-78-5
MF:C29H24Cl2N2O7S
MW:615.48
EINECS:813-044-8
MDL No.:MFCD28502439
Properties
Appearance White to Off-White Solid
Melting point:>163°C (dec.)
Boiling point:811.9±65.0 °C
Density 1.479±0.06 g/cm3
storage temp. Hygroscopic, -20°C Freezer, Under inert atmosphere
Application:
Lifitegrast reduces the aggregation of white blood cells in the eye by blocking the interaction between LFA-1 and ICAM-1, thereby alleviating eye inflammation and dry eye symptoms. This mechanism makes Lifitegrast have potential in the treatment of dry eye disease.
| Detailed Applications |
1. Clinical Pharmaceutical ▶ First FDA-approved prescription drug for treating signs and symptoms of moderate to severe Dry Eye Disease (DED). ▶ Acts as a novel small-molecule LFA-1 (lymphocyte function-associated antigen-1) antagonist, inhibits LFA-1/ICAM-1 binding, blocks ocular surface inflammatory response, relieves dryness, irritation, burning, redness and blurred vision caused by DED. ▶ Unique mechanism: targets the inflammatory root of dry eye, not just symptomatic relief, with long-term therapeutic effect.
2. Pharmaceutical API Production ▶ Active pharmaceutical ingredient (API) for manufacturing Xiidra® (the commercial eye drop preparation of Lifitegrast).
3. Biomedical Research ▶ Used in laboratory research of ocular inflammation, T cell-mediated immune diseases, corneal injury and diabetic retinal complications. ▶ Applied in anti-inflammatory drug development and integrin receptor antagonist mechanism research (IC50=2.98 nM for LFA-1 inhibition). |
| Packaging Specifications |
▶ Commercial Finished Product (Xiidra® Ophthalmic Solution) 1. Primary packaging: Sterile low-density polyethylene (LDPE) single-use vials, 0.2mL per vial (contains 10mg Lifitegrast active ingredient). 2. Secondary packaging: Aluminum foil light-proof bags, 5 vials/bag or 60 vials/box (standard clinical package). 3. Sealing: Tamper-evident seal, sterile aseptic packaging to prevent microbial contamination.
▶ API Raw Material Packaging (Industrial/Lab Grade) 1. Lab-scale packaging: Amber glass vials with Teflon-lined caps, specifications: 5mg, 10mg, 25mg, 50mg, 100mg, 500mg (purity ≥99%). 2. Industrial production packaging: HDPE plastic drums/fiber drums with inner PE film, 1kg, 5kg, 25kg per drum; vacuum-sealed for moisture proof.
▶ Storage & Shelf Life Requirements 1. Finished eye drops: Store at 20°C-25°C (68°F-77°F), allow brief 15°C-30°C storage; avoid direct sunlight, freezing and high humidity; shelf life 24 months in original packaging. 2. API raw material: Sealed storage at 2°C-8°C (cold chain), dry and anaerobic environment; shelf life 18 months under standard storage; normal transportation for bulk goods, cold chain for small batch lab products. |
Synonyms:
Lifitegrast
1025967-78-5
Xiidra
SAR-1118
(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid
SHP-606
L-Phenylalanine, N-[[2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-
SAR1118
L-Phenylalanine, N-((2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl)-3-(methylsulfonyl)-
(2S)-2-(((2-(benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6-yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid
(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid
Lifitegrast
lifitegrastum
L-Phenylalanine, N-[[2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-; N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine; (S)
N-(2-(1-benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(methanesulfonyl)-L-phenylalanine
(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid;(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid
(2S)-2-(((2-(Benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6- yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid
Hot Tags: 1025967-78-5 liftegrast, China 1025967-78-5 liftegrast manufacturers, suppliers, api local api integration, api deployment, api role based access control api integration, api compatibility, api voice assistant powered api integration, api multi factor authentication api integration


